FDA Approved: NELARABINE — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved Nelarabine under an Original Application from Sagent Pharmaceuticals. It is indicated for T-cell acute lymphoblastic leukemia and T-cell lymphoblas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoblastic Lymphoma

Drugs mentioned

• Nelarabine (Nelarabine)

Snippet

ORIG AP for NELARABINE (NELARABINE)